Pre-Annual General Meeting Information • Mar 24, 2025
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer

SIG plc (Registered in England No. 00998314)
SIG plc's Annual General Meeting will be held at SIG West London, Mathisen Way, Poyle, Slough SL3 0HB on Thursday 1 May 2025 at 9.30am
If you are in any doubt as to the action you should take you should immediately seek advice from your stockbroker, bank manager, solicitor, accountant or other independent professional advisor duly authorised under the Financial Services and Markets Act 2000.
If you have sold or otherwise transferred all of your shares in SIG plc, please forward this document and any accompanying documents, with the exception of any personalised documents, as soon as possible to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for transmission to the purchaser or transferee. A copy of this Notice, and other information required by section 311A of the Companies Act 2006, can be found in the Investors section at www.sigplc.com. The Notice of Annual General Meeting is set out on pages 6 to 9 of this document. A Form of Proxy for use at the Annual General Meeting is enclosed.
The Annual General Meeting (the "AGM") of SIG plc (the "Company") will be held at 9.30am on Thursday 1 May 2025 at SIG West London, Mathisen Way, Poyle, Slough SL3 0HB.
We consider the AGM to be an important event in our calendar and an opportunity for the Board of Directors to engage with our shareholders. Each Chair of the Board's Audit & Risk, Remuneration and Nominations Committees will be available at the AGM to answer any questions arising from the work of those Committees.
If you would like to ask a question relating to the business of the AGM in advance, please email us at [email protected] no later than 48 hours before the AGM is due to take place.
All questions submitted in advance will be answered at the meeting where possible. We encourage you to monitor our website at www.sigplc.com where we will communicate any additional information relating to the AGM arrangements, should the need arise.
The formal Notice of AGM of the Company is set out on pages 6 to 9 and an explanation of the business to be considered and voted on at the AGM is set out in this letter.
The Chairman will present the audited Annual Report and Accounts of the Company for the year ended 31 December 2024 to the meeting. Shareholders are asked to receive the reports of the Directors and the Auditor, the Strategic Report and the Financial Statements for the year ended 31 December 2024.
The Directors' Remuneration Report is set out in the 2024 Annual Report and Accounts on pages 98 to 119. Resolution 2 is the ordinary resolution to approve the Directors' Remuneration Report. The vote upon the Directors' Remuneration Report is advisory and does not affect the future remuneration paid to any Director.
The report gives details of the Directors' remuneration for the year ended 31 December 2024. The report also includes a statement from the Chair of the Remuneration Committee and details of the Remuneration Committee's representations and activities. The Company's Auditor, Ernst & Young LLP, have audited those parts of the Directors' Remuneration Report which are required to be audited and their report is issued in the Annual Report and Accounts. This resolution is put to shareholders annually as required by the Companies Act 2006 (the "Act").
All current Directors are seeking re-election at the AGM in accordance with the requirements of the 2018 UK Corporate Governance Code, with the exception of Gillian Kent, who has informed the Company that she does not intend to seek re-election at the AGM and therefore shall retire from the Board at the conclusion of the AGM.
The Board is confident that following Gillian's retirement it shall continue to have the appropriate skills, experience and knowledge to support the Company on the next phase of delivery of its strategy. The Company will keep under review the size and composition of the Board to ensure that this remains the case.
It is the view of the Board that each of the Non-Executive Directors standing for re-election brings considerable management experience and independent perspective to the Board's discussions and that each of the independent Non-Executive Directors standing for re-election is considered to be independent of management and free from any relationship or circumstance that could affect, or appear to affect, the exercise of their independent judgement. Bruno Deschamps and Diego Straziota are nonindependent Non-Executive Directors nominated by CD&R. The Board believes that their contribution has been considerable and that they bring independent thought and challenge to the Board.
The Board has confirmed, following a formal performance review, that the Directors standing for re-election make an effective and valuable contribution to the Board and are able to dedicate sufficient time to their role and responsibilities. I strongly recommend that you vote in favour of the re-election of the Directors standing for re-election. Biographical details of the Directors standing for re-election, including details of their contribution and how it is, and continues to be, important to the Company's long-term sustainable success, are included on pages 10 and 11 of this document.
The Auditor of the Company is subject to re-appointment at each Annual General Meeting. On recommendation of the Audit & Risk Committee, Resolution 12 proposes that Ernst & Young LLP be re-appointed as the Company's Auditor to hold office until the next general meeting at which financial statements are laid before the Company.
Resolution 13 authorises the Audit & Risk Committee to determine the external Auditor's remuneration.
Part 14 of the Act requires companies to obtain shareholders' authority for political donations to registered political parties, other political organisations or an independent election candidate and for any political expenditure.
The definitions of 'political donations' and 'political expenditure' under the Act are wide and as a result it is possible that they may include, for example, sponsorship, subscriptions, paid leave for employees fulfilling certain public duties and/or bodies concerned with policy review and law reform.
Notwithstanding that the Company has not made a political donation in the past and has no intention either now or in the future of making any political donation or incurring any political expenditure, the Board has decided to propose Resolution 14 to shareholders to seek authority for the Company to make political donations. The Resolution will allow the Company to support the community and put forward its views to wider business and Government entities without the risk of inadvertently breaching the Act.
The authority is subject to a maximum aggregate amount of £50,000 and will cover the period from the date that Resolution 14 is passed until the end of the next Annual General Meeting of the Company or, if earlier on 30 June 2026.
Resolution 15 seeks to renew the Directors' authority to allot shares.
At the last Annual General Meeting of the Company held on 2 May 2024, the Directors were given authority to allot ordinary shares in the capital of the Company up to a maximum nominal amount of £78,770,466, representing approximately two-thirds of the Company's then issued ordinary share capital. This authority expires at the conclusion of the AGM. Resolution 15 will, if passed, renew this authority, in line with the guidelines published by the Investment Association ("IA") in February 2023.
The IA guidelines on Directors' authority to allot shares state that IA members will regard as routine an authority to allot up to two-thirds of the existing issued share capital, provided that any amount in excess of one-third of existing issued shares can be applied to fully pre-emptive offers only.
In light of these guidelines, the Board considers it appropriate that the Directors be granted authority to allot shares in the capital of the Company up to a maximum nominal amount of £78,770,464 representing the guideline limit of approximately two-thirds of the Company's issued ordinary share capital as at 11 March 2025 (the latest practicable date prior to the publication of this document). Of this amount, a maximum nominal amount of £39,385,232 (representing approximately one-third of the Company's issued ordinary share capital) can only be allotted pursuant to a fully pre-emptive offer. The authority will last until the conclusion of the next Annual General Meeting of the Company or, if earlier, 30 June 2026. The Directors have no present intention of exercising this authority, however they consider it appropriate to maintain the flexibility that this authority provides.
As at the date of this letter, the Company does not hold any ordinary shares in the capital of the Company in treasury.
Resolutions 16 and 17 are proposed as Special Resolutions to give the Directors authority to allot ordinary shares in the capital of the Company pursuant to the authority granted under Resolution 15 above for cash (and/or sell any treasury shares for cash) without complying with the pre-emption rights in the Companies Act 2006 in limited circumstances.
Resolution 16 will permit the Directors to allot:
Resolution 17 will permit the Directors to allot additional equity securities for cash and sell treasury shares up to a maximum nominal value of £5,907,784, representing a further 5% of the issued ordinary share capital of the Company otherwise than in connection with a pre-emptive offer to existing shareholders for the purpose of financing a transaction (or refinancing within twelve months of the transaction) which the Directors determine to be an acquisition or other capital investment as contemplated by the Pre-Emption Group's Statement of Principles, and which is announced contemporaneously with the allotment, or has taken place in the preceding twelve-month period and is disclosed in the announcement of the allotment. The Directors believe that it is appropriate to seek this additional 5% authority in Resolution 17 to give the Company the flexibility that this resolution affords.
The maximum nominal value of equity securities which could be allotted if the authorities contained in Resolutions 16(b) and 17 were both used would be £11,815,568, which represents approximately 10% of the issued ordinary share capital of the Company, at 11 March 2025, (being the latest practicable date prior to publication of this document).
The Directors have no present intention of exercising these authorities to issue ordinary shares, however they consider it appropriate to maintain flexibility that these authorities provide. The authorities contained in Resolutions 16 and 17 will expire upon the earlier of the end of the next Annual General Meeting of the Company or 30 June 2026.
The Directors confirm that they intend to follow the shareholder protections in paragraph one of Part 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of the Notice of AGM.
The Directors are aware of the Pre-Emption Group's most recent Statement of Principles on Disapplying Pre-emption Rights published in November 2022. However, at this time, in resolutions 16 and 17 the Directors consider it appropriate to seek the previous limits of 5 per cent of the issued ordinary share capital of the Company.
It is a requirement of Section 693 of the Act that a company shall not make a market purchase of its own shares unless the purchase has first been authorised by the Company at a general meeting. Accordingly, Resolution 18 to be proposed as a Special Resolution gives the Directors power to make market purchases of the Company's shares up to a maximum amount of 118,155,697 ordinary shares (representing approximately 10% of the current issued ordinary share capital of the Company as at 11 March 2025 (the latest practicable date prior to the publication of this document)). This power will expire at the conclusion of the next Annual General Meeting of the Company or, if earlier, 30 June 2026. It is intended that purchases will only be made on the London Stock Exchange.
The Directors consider that it is in the best interests of all shareholders that the Company should have the flexibility to make market purchases of its own shares; however, this is not intended to imply that the shares will be purchased. The Directors would make such purchases only if it would be in the best interests of shareholders generally (taking into account, for example, the financial resources of the Company, the Company's share price and future funding opportunities) and if such purchases would result in an increase in earnings per share.
Listed companies purchasing their own shares are allowed to hold them in treasury as an alternative to cancelling them. No dividends are paid on shares while they are held in treasury and no voting rights attach to the treasury shares. If Resolution 18 is passed, it is the Company's intention to hold any shares purchased in treasury for use in connection with the Company's employee share schemes. However, in order to respond properly to the Company's capital requirements and prevailing market conditions, the Directors will reassess at the time of any and each actual purchase whether to hold the shares in treasury or cancel them, provided it is permitted to do so. The Company currently holds no ordinary shares in treasury.
The Directors have no current intention of using the powers sought under Resolution 18, but as noted above, consider it advisable to pass this Resolution in order that they can be prepared to take advantage of future situations which may arise.
As at 11 March 2025 (the latest practicable date prior to the publication of this document), there were Directors' options outstanding over 9,719,592 ordinary shares in the capital of the Company representing 0.82% of the Company's issued ordinary share capital.
If the authority to purchase the Company's ordinary shares being sought in Resolution 18, and the existing authority to purchase ordinary shares taken at last year's Annual General Meeting (which expires at the end of the AGM) were exercised in full, these options would represent 0.91% of the Company's issued ordinary share capital.
Resolution 19 is a resolution to allow the Company to hold general meetings (other than Annual General Meetings) on 14 clear days' notice.
General meetings (other than Annual General Meetings) must be held on 21 clear days' notice unless shareholders approve a shorter notice period, which cannot be less than 14 clear days. Annual General Meetings must always be held on at least 21 clear days' notice. In order to be able to call a general meeting on less than 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders for that meeting. This condition is met if the company offers a facility, accessible to all shareholders, to appoint a proxy by means of a website.
The Directors are proposing Resolution 19 as a Special Resolution to approve 14 clear days as the minimum period of notice for all general meetings of the Company other than Annual General Meetings. The approval of this Resolution will be effective until the end of the next Annual General Meeting of the Company, when it is intended that the approval will be renewed. The Board will consider on a case-by-case basis whether the use of the flexibility offered by the shorter notice period is merited, taking into account the circumstances, including whether the business of the meeting is time-sensitive and whether it is thought to be to the advantage of shareholders as a whole.
Notice is hereby given that the SIG plc 2024 Annual Report and Accounts has been published on the Company's website at www.sigplc.com/investors/results-reports-and-presentations. If you have elected to receive shareholder correspondence in hard copy, then the Annual Report and Accounts will accompany this Notice. Should you wish to change your election at any time, you can do so by contacting our Registrars, Computershare, on 0370 707 1293. Operator assistance is available between 8.30am and 5.30pm each business day. Callers from outside the UK should dial +44 370 707 1293.
Your vote is important, and I would encourage you, regardless of the number of shares you own, to complete, sign and return the Form of Proxy so as to reach the Company's Registrars, Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS99 6ZY, not less than 48 hours before the time fixed for the holding of the AGM. Alternatively, shareholders may also register their proxy appointment and voting instructions electronically. Please refer to the notes on pages 8 and 9 of this document for further details on how to appoint a proxy and vote electronically. The deadline for the receipt by our Registrars of all proxy appointments is 9.30am on 29 April 2025. Voting will be by poll this year.
The Board considers that all the Resolutions set out in the 2025 Notice of Annual General Meeting are likely to promote the success of the Company and are in the best interests of the Company and its shareholders as a whole. The Directors unanimously recommend that you vote in favour of the proposed Resolutions as they intend to do in respect of their personal shareholdings in the Company, which, in aggregate, amount to 3,734,217 shares representing 0.32% of the issued ordinary share capital of the Company.
Yours faithfully
Andrew Allner Chairman 12 March 2025
Registered Office: Adsetts House, 16 Europa View, Sheffield Business Park, Sheffield S9 1XH Registered in England and Wales under Company Number: 00998314
Notice is hereby given that the Annual General Meeting ("AGM") of the members of SIG plc (the "Company") will be held at SIG West London, Mathisen Way, Poyle, Slough SL3 0HB on 1 May 2025 at 9.30am (the "2025 AGM" or the "Meeting") to consider and, if thought fit, to pass Resolutions 1 to 15 inclusive as ordinary resolutions and Resolutions 16 to 19 inclusive as special resolutions.
provided that the aggregate amount of any such donations and expenditure shall not exceed £50,000.
For the purposes of this Resolution the terms "political donations", "independent election candidates", "political organisations", "political expenditure" and "political party" have the meanings as set out in Sections 363 to 365 of the Companies Act 2006.
provided that this authority shall expire at the end of the next Annual General Meeting of the Company after the passing of this Resolution or, if earlier, on 30 June 2026, save that the Company shall be entitled to make offers or agreements before the expiry of such authority which would or might require shares to be allotted or Rights to be granted after such expiry and the Directors shall be entitled to allot shares and grant Rights pursuant to any such offer or agreement as if this authority had not expired.
That, if Resolution 15 is passed, the Directors be and they are hereby empowered pursuant to Sections 570 and 573 of the Companies Act 2006 to allot equity securities (within the meaning of Section 560 of the Companies Act 2006) for cash either pursuant to the authority conferred by Resolution 15 above or by way of a sale of treasury shares as if Section 561(1) of the Companies Act 2006 did not apply to any such allotment or sale provided that this power shall be limited to:
(a) the allotment of equity securities or sale of treasury shares in connection with a fully pre-emptive offer in favour of (A) the holders of ordinary shares on the register of members at such record dates as the Directors may determine where the equity securities respectively attributable to the interests of the ordinary shareholders are proportionate (as nearly as may be practicable) to the respective numbers of ordinary shares held or deemed to be held by them on any such record dates, and (B) the holders of other equity securities if this is required by the rights of those securities or, if the Directors consider it necessary, as permitted by the rights of those securities, subject in either case to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements or legal or practical problems arising under the laws of any territory or the requirements of any regulatory body or stock exchange or by virtue of shares being represented by depository receipts or any other matter; and
such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or, if earlier, on 30 June 2026 but, in each case, prior to its expiry the Company shall be entitled to make offers or agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Directors shall be entitled to allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or, if earlier, on 30 June 2026, but in each case prior to its expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
By order of the Board
Group General Counsel & Company Secretary
12 March 2025
Registered Office: Adsetts House, 16 Europa View, Sheffield Business Park, Sheffield S9 1XH
Registered in England and Wales under Company Number: 00998314


Andrew Allner Non-Executive Chairman1
R N
Appointed as

Gavin Slark Chief Executive Officer
Appointed as an Executive Director and Chief Executive Officer on 1 February 2023.

Ian Ashton Chief Financial Officer

Kath Durrant Senior Independent Director
Appointed as an Independent Non-Executive Director and Remuneration Committee Chair on 1 January 2021. Appointed as Senior Independent Director in September 2023.
Career and experience
Kath has held senior roles at GlaxoSmithKline plc and AstraZeneca plc. She was formerly Group Human Resources Director at Rolls Royce plc and Ferguson plc and served as Chief Human Resources Officer of CRH plc. She has served as a Non-Executive Director and Chair of the Remuneration Committee of Vesuvius plc, Renishaw plc and Calisen plc. Kath brings substantial leadership experience across a range of businesses and has a strong track record of chairing the remuneration committees of publicly listed companies.
Key strengths Strong leadership and human resources experience across a range of businesses, transformation and change management, construction industry and international experience.
Non-Executive Director and Remuneration Committee Chair at Essentra plc and Anglian Water Services Limited.

Alan Lovell Non-Executive Director
Appointed as an Independent Non-Executive Director on 1 August 2018.
Career and experience Alan brings extensive leadership experience to the Board, having served as Chief Executive Officer at six companies, including Jarvis plc and Costain Group plc. He has also been Chair of several listed companies, including Interserve Group Limited, Progressive Energy Ltd and the Consumer Council for Water.
Non-Executive Chairman on 1 November 2017.
Andrew brings extensive experience serving on the boards of publicly listed companies as Chairman and as a Non- Executive Director. He was previously Chairman at Shepherd Building Group Limited, Eco Buildings Group plc, The Go-Ahead Group plc and Marshalls plc, and a Non-Executive Director at Northgate plc, AZ Electronic Materials SA and CSR plc. Andrew has held executive roles as Group Finance Director of RHM plc and CEO of Enodis plc. He has also held senior executive positions with Dalgety plc, Amersham International plc and Guinness plc. He has significant experience in managing and navigating challenging situations.
Key external appointments None
Substantial board, leadership, strategy, international and general management, corporate transaction, governance and accounting expertise.
Executive Officer at Grafton Group plc, an international distributor of building materials and DIY retailer, for 11 years from 2011. Prior to that he held the position of Group CEO at BSS Group plc, a prominent UK distributor for specialised trades including plumbing, heating, and construction sectors. Gavin has extensive leadership experience in the pan-European construction distribution sector and a proven track record of driving shareholder value in publicly listed companies.
Significant in-depth knowledge and years of experience in the distribution sector, shaping strategy and culture, product knowledge, leadership and management.
served as Chief Financial Officer at Low & Bonar plc until its acquisition by the Freudenberg group. Before that, he was Chief Financial Officer of Labviva LLC, a US-based technology company. Ian spent a significant portion of his career at Smith & Nephew plc, where he held various senior finance positions in the UK, USA, and Asia. Ian is a qualified chartered accountant and began his Ian brings extensive UK and international financial and accounting expertise to the Board and to his role as Chief Financial Officer.
Broad global experience in a series of financial leadership roles. A strong track record in corporate transactions, driving change, accounting/ finance and stakeholder engagement with significant international experience.
Accounting and finance, corporate transactions and extensive construction industry and turnaround experience in the UK and Europe.
Key external appointments Chair of the Environment Agency.
Key external appointments None
Key external appointments None
Career and experience
Appointed as an Executive Director and Chief Financial Officer on 1 July 2020.
career at Ernst & Young LLP.
A Audit & Risk Committee
Bruno Deschamps Non-Executive Director
Career and experience Bruno is an Operating Advisor to CD&R LLP and the Chairman and CEO of Entrepreneurs Partners LLP. He is a former Chairman of Diversey (USA) and Kloeckner Pentaplast (Germany). He has served as Managing Partner of 3i Plc Group, Operating Partner of CD&R where he played a pivotal role in the firm's investments in Brakes, as Chairman, and CEO in Culligan, Rexel and VWR. Bruno was president and COO of Ecolab Inc (USA), and President and CEO of Henkel Ecolab, Teroson Gmbh, VP Henkel Industrial Adhesives (Germany), and Chairman and CEO of SAIM (France). Bruno is a Knight of the Legion d'Honneur (France).
Appointed as a Non-Executive Director on 10 July 2020.
N Nominations Committee Chair of Committee I Independent Director
Shatish Dasani Non-Executive Director
Appointed as an Independent Non-Executive Director and Chair of the Audit & Risk Committee on 1 February 2021.
Shatish has over 30 years' experience in senior public company finance roles across various sectors, including building materials, advanced electronics, engineering, general industrial, business services, construction, and infrastructure. He also has extensive international experience including as a regional CFO in South America. He was previously Chief Financial Officer of Forterra plc and TT Electronics plc and has served as an alternative Non-Executive Director for Camelot Group plc and as a Public Member at Network Rail plc.
Strategy development and execution, performance improvement, financial management, corporate finance, mergers and acquisitions. Sector experience of building materials, advanced electronics, general industrial, business services and infrastructure.
Senior Independent Director and Audit & Risk Committee Chair of Renew Holdings plc. Non-Executive Director and Audit & Risk Committee Chair at Speedy Hire plc and Genuit Group plc. Trustee and Chair of UNICEF UK.
Simon King Non-Executive Director
Appointed as an Independent Non-Executive Director on 1 July 2020. Simon is the Designated Non-Executive Director for Workforce Engagement.
Simon most recently served as a Non-Executive Director for Headlam Group plc. Simon has extensive experience in the construction sector having served on the Travis Perkins Executive Board and as CEO of Wickes. Previously, he worked at Walmart as Chief Operating Officer of Asda and served as CEO at Savola Group Middle East. Simon has held CEO positions for Tesco in Turkey and South Korea, where he led the joint venture with Samsung. Before his role at Tesco South Korea, Simon served as Chief Commercial Officer for Tesco in central Europe.
Over 35 years' experience leading international teams, building products distribution experience, change management, retail and distribution, marketing, technology/digital and stakeholder engagement experience, particularly in the workforce.
Non-Executive Chairman at Troy (UK) Limited. Non-Executive Director at James Donaldson Group Ltd and Chairman at Smoking Lobster Restaurants (Isle of Wight).
Diego possesses a wealth of sector-specific knowledge and has a track record in strategy development and corporate transactions. His expertise extends to driving and overseeing improvements in company performance.
appointments Holds a Directorship in Wolseley, a CD&R portfolio company.

Diego Straziota Non-Executive Director
Appointed as a Non-Executive Director on 4 May 2023.
Diego is a Managing Director at CD&R LLP and holds a directorship in Wolseley, a CD&R portfolio company. Since joining CD&R in 2017 Diego has played an instrumental role in CD&R's investments in Opella, UDG and the subsequent separation of UDG from Inizio and Sharp, Westbury Street Holdings and Wolseley. Diego is responsible for investment activities in European Industrials at CD&R. Prior to joining CD&R, he worked in the private equity division of Blackstone.
Key strengths
Deep industrial knowledge, corporate transactions, and extensive experience in driving and overseeing improved company performance.
appointments Directorships in the following CD&R portfolio companies: Kalle Gmbh, OCS Group and Wolseley, of which he is also Chairman.
Have a question? We'll get back to you promptly.